D011464Chemicals & DrugsD10.251.355.255.550.550.500D23.469.050.175.725.550.50022460.97529Epoprostenolprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson0.8221430.019432622research area of0.7461560.01248366subject area for31912412Kimmig LM, Liao C, Bag RLungAmbulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension. Lung. 2020 02; 198(1):53-58.Lung2020-01-07T00:00:002020Ambulatory Transition from Parenteral Prostanoid to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension.LucasKimmigLucas Kimmig41.7886000000000087.598699999999993927Kimmig, LucasAssistant ProfessorMedicine-Pulmonary and Critical CareMedicinePathologyUniversity of ChicagoAliyaHusainAliya Husain41.78927490000000-87.601250000000001655Husain, AliyaProfessorStephenArcherStephen Archer41.78927490000000-87.601250000000002615Archer, StephenProfessorJonathanRichJonathan Rich41.78927490000000-87.6012500000000041Rich, JonathanAsst Prof-Clinical Depttrue1Asst Prof-Clinical DeptAsst Prof-Clinical Depttrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessor25793960Provencher S, Paruchuru P, Spezzi A, Waterhouse B, Gomberg-Maitland M, pH12 Flolan reformulation study groupPloS oneQuality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertension. PLoS One. 2015; 10(3):e0120657.PLoS One2015-03-20T00:00:002015Quality of life, safety and efficacy profile of thermostable flolan in pulmonary arterial hypertension.26075562Hill NS, Badesch D, Benza RL, D'Eletto TA, Farber HW, Gomberg-Maitland M, Hassoun PM, Preston IAnnals of the American Thoracic SocietyReply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration. Ann Am Thorac Soc. 2015 Jun; 12(6):960.Ann Am Thorac Soc2015-06-01T00:00:002015Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.RemziBagRemzi Bag0.000000000000000.000000000000003160Bag, RemziAssociate Professor26437815Bonham CA, Oldham JM, Gomberg-Maitland M, Vij RChestProstacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series. Chest. 2015 Oct; 148(4):1055-1062.Chest2015-10-01T00:00:002015Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series.27396777Bourge RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, Tarver JH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Torres F, Cerkvenik J, Morris M, Thalin M, Peterson L, Rubin LJChestTreprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial. Chest. 2016 Jul; 150(1):27-34.Chest2016-01-13T00:00:002016Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.